ERNA
Eterna Therapeutics Inc
NASDAQ: ERNA · HEALTHCARE · BIOTECHNOLOGY
$0.15
-21.24% today
Updated 2026-04-30
Market cap
$5.59M
P/E ratio
—
P/S ratio
1,275.37x
EPS (TTM)
$-2.24
Dividend yield
—
52W range
$0 – $4
Volume
1.1M
Eterna Therapeutics Inc (ERNA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+85.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.2%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-1.2%
2025-11-07
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-07 | $-0.15 | — | $1.69 | $1.67 | -1.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 | $-0.15 | — | — | — |
| 2025-06-30 | $0.00 | $-0.61 | — | — | — |
| 2025-03-31 | $0.00 | $-2.31 | — | — | — |
| 2024-12-31 | $0.00 | $-0.15 | — | $1000.00 | — |
| 2023-09-30 | — | $-1.03 | — | $51000.00 | — |
| 2023-06-30 | — | $-0.85 | — | — | — |
| 2023-03-31 | $-0.14 | $-1.24 | -785.7% | — | — |
| 2022-12-31 | $-0.14 | $-1.24 | -785.7% | — | — |
| 2022-09-30 | $-2.20 | $-2.49 | -13.2% | — | — |
| 2022-06-30 | $-2.60 | $-1.20 | +53.8% | — | — |
| 2022-03-31 | $-2.50 | $-3.20 | -28.0% | — | — |
| 2021-12-31 | $-37.50 | $-3.20 | +91.5% | — | — |
Frequently asked questions
Has Eterna Therapeutics Inc beaten earnings estimates?
Eterna Therapeutics Inc has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports.
How does ERNA stock react to earnings?
ERNA stock has moved an average of -1.2% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.